Isr Med Assoc J
-
Randomized Controlled Trial Multicenter Study
Efficacy and Safety of Enteral Recombinant Human Insulin for Reduction of Time-to-Full Enteral Feeding in Preterm Infants: A Randomized, Double-blind, Placebo-Controlled Trial.
Infants born very prematurely have functionally and structurally immature gastrointestinal tracts. ⋯ Our trial demonstrated that administration of enteral rh-insulin as supplement to enteral nutrition significantly reduced time to achieve full enteral feeding in preterm infants with a gestational age of 26-33 weeks.